The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Eye Injection Market Research Report 2025
Synopsis
The global Eye Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eye Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eye Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eye Injection include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eye Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Injection.
Report Scope
The Eye Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eye Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Roche
Fagron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Segment by Application
Age-related Macular Degeneration (AMD)
Diabetic Retinopathy
Retinal Vein Occlusion (RVO)
Retinopathy of Prematurity (ROP)
Uveitis
Neovascular Glaucoma
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eye Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eye Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Eye Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eye Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eye Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eye Injection include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eye Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Injection.
Report Scope
The Eye Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eye Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Roche
Fagron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Segment by Application
Age-related Macular Degeneration (AMD)
Diabetic Retinopathy
Retinal Vein Occlusion (RVO)
Retinopathy of Prematurity (ROP)
Uveitis
Neovascular Glaucoma
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eye Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eye Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Eye Injection Market Overview
1.1 Product Overview and Scope of Eye Injection
1.2 Eye Injection Segment by Type
1.2.1 Global Eye Injection Market Value Comparison by Type (2024-2030)
1.2.2 Ranibizumab
1.2.3 Bevacizumab
1.2.4 Aflibercept
1.2.5 Brolucizumab
1.2.6 Faricimab
1.2.7 Others
1.3 Eye Injection Segment by Application
1.3.1 Global Eye Injection Market Value by Application: (2024-2030)
1.3.2 Age-related Macular Degeneration (AMD)
1.3.3 Diabetic Retinopathy
1.3.4 Retinal Vein Occlusion (RVO)
1.3.5 Retinopathy of Prematurity (ROP)
1.3.6 Uveitis
1.3.7 Neovascular Glaucoma
1.3.8 Others
1.4 Global Eye Injection Market Size Estimates and Forecasts
1.4.1 Global Eye Injection Revenue 2019-2030
1.4.2 Global Eye Injection Sales 2019-2030
1.4.3 Global Eye Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eye Injection Market Competition by Manufacturers
2.1 Global Eye Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eye Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eye Injection Average Price by Manufacturers (2019-2024)
2.4 Global Eye Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eye Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eye Injection, Product Type & Application
2.7 Eye Injection Market Competitive Situation and Trends
2.7.1 Eye Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Eye Injection Players Market Share by Revenue
2.7.3 Global Eye Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Eye Injection Retrospective Market Scenario by Region
3.1 Global Eye Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eye Injection Global Eye Injection Sales by Region: 2019-2030
3.2.1 Global Eye Injection Sales by Region: 2019-2024
3.2.2 Global Eye Injection Sales by Region: 2025-2030
3.3 Global Eye Injection Global Eye Injection Revenue by Region: 2019-2030
3.3.1 Global Eye Injection Revenue by Region: 2019-2024
3.3.2 Global Eye Injection Revenue by Region: 2025-2030
3.4 North America Eye Injection Market Facts & Figures by Country
3.4.1 North America Eye Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eye Injection Sales by Country (2019-2030)
3.4.3 North America Eye Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eye Injection Market Facts & Figures by Country
3.5.1 Europe Eye Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eye Injection Sales by Country (2019-2030)
3.5.3 Europe Eye Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Eye Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Eye Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eye Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Eye Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Eye Injection Market Facts & Figures by Country
3.7.1 Latin America Eye Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eye Injection Sales by Country (2019-2030)
3.7.3 Latin America Eye Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eye Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Eye Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eye Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eye Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eye Injection Sales by Type (2019-2030)
4.1.1 Global Eye Injection Sales by Type (2019-2024)
4.1.2 Global Eye Injection Sales by Type (2025-2030)
4.1.3 Global Eye Injection Sales Market Share by Type (2019-2030)
4.2 Global Eye Injection Revenue by Type (2019-2030)
4.2.1 Global Eye Injection Revenue by Type (2019-2024)
4.2.2 Global Eye Injection Revenue by Type (2025-2030)
4.2.3 Global Eye Injection Revenue Market Share by Type (2019-2030)
4.3 Global Eye Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eye Injection Sales by Application (2019-2030)
5.1.1 Global Eye Injection Sales by Application (2019-2024)
5.1.2 Global Eye Injection Sales by Application (2025-2030)
5.1.3 Global Eye Injection Sales Market Share by Application (2019-2030)
5.2 Global Eye Injection Revenue by Application (2019-2030)
5.2.1 Global Eye Injection Revenue by Application (2019-2024)
5.2.2 Global Eye Injection Revenue by Application (2025-2030)
5.2.3 Global Eye Injection Revenue Market Share by Application (2019-2030)
5.3 Global Eye Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Eye Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Eye Injection Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Eye Injection Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Genentech
6.4.1 Genentech Corporation Information
6.4.2 Genentech Description and Business Overview
6.4.3 Genentech Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genentech Eye Injection Product Portfolio
6.4.5 Genentech Recent Developments/Updates
6.5 Apellis Pharmaceuticals, Inc.
6.5.1 Apellis Pharmaceuticals, Inc. Corporation Information
6.5.2 Apellis Pharmaceuticals, Inc. Description and Business Overview
6.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apellis Pharmaceuticals, Inc. Eye Injection Product Portfolio
6.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Coherus BioSciences Inc.
6.6.1 Coherus BioSciences Inc. Corporation Information
6.6.2 Coherus BioSciences Inc. Description and Business Overview
6.6.3 Coherus BioSciences Inc. Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Coherus BioSciences Inc. Eye Injection Product Portfolio
6.6.5 Coherus BioSciences Inc. Recent Developments/Updates
6.7 Iveric Bio
6.6.1 Iveric Bio
Corporation Information
6.6.2 Iveric Bio
Description and Business Overview
6.6.3 Iveric Bio
Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Iveric Bio
Eye Injection Product Portfolio
6.7.5 Iveric Bio
Recent Developments/Updates
6.8 Regeneron
6.8.1 Regeneron Corporation Information
6.8.2 Regeneron Description and Business Overview
6.8.3 Regeneron Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Regeneron Eye Injection Product Portfolio
6.8.5 Regeneron Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Eye Injection Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Fagron
6.10.1 Fagron Corporation Information
6.10.2 Fagron Description and Business Overview
6.10.3 Fagron Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fagron Eye Injection Product Portfolio
6.10.5 Fagron Recent Developments/Updates
6.11 Qilu Pharmaceutical Co.,Ltd.
6.11.1 Qilu Pharmaceutical Co.,Ltd. Corporation Information
6.11.2 Qilu Pharmaceutical Co.,Ltd. Eye Injection Description and Business Overview
6.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product Portfolio
6.11.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.12 Chengdu Kanghong Pharmaceutical Group
6.12.1 Chengdu Kanghong Pharmaceutical Group Corporation Information
6.12.2 Chengdu Kanghong Pharmaceutical Group Eye Injection Description and Business Overview
6.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chengdu Kanghong Pharmaceutical Group Eye Injection Product Portfolio
6.12.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eye Injection Industry Chain Analysis
7.2 Eye Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eye Injection Production Mode & Process
7.4 Eye Injection Sales and Marketing
7.4.1 Eye Injection Sales Channels
7.4.2 Eye Injection Distributors
7.5 Eye Injection Customers
8 Eye Injection Market Dynamics
8.1 Eye Injection Industry Trends
8.2 Eye Injection Market Drivers
8.3 Eye Injection Market Challenges
8.4 Eye Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Eye Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Eye Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Eye Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Eye Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Eye Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Eye Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Eye Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Eye Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Eye Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Eye Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Eye Injection, Product Type & Application
Table 12. Global Key Manufacturers of Eye Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Eye Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Eye Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Eye Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Eye Injection Sales Market Share by Region (2019-2024)
Table 19. Global Eye Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Eye Injection Sales Market Share by Region (2025-2030)
Table 21. Global Eye Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Eye Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Eye Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Eye Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Eye Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Eye Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Eye Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Eye Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Eye Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Eye Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Eye Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Eye Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Eye Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Eye Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Eye Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Eye Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Eye Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Eye Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Eye Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Eye Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Eye Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Eye Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Eye Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Eye Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Eye Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Eye Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Eye Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Eye Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Eye Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Eye Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Eye Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Eye Injection Sales Market Share by Type (2019-2024)
Table 53. Global Eye Injection Sales Market Share by Type (2025-2030)
Table 54. Global Eye Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Eye Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Eye Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Eye Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Eye Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Eye Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Eye Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Eye Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Eye Injection Sales Market Share by Application (2019-2024)
Table 63. Global Eye Injection Sales Market Share by Application (2025-2030)
Table 64. Global Eye Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Eye Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Eye Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Eye Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Eye Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Eye Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Eye Injection Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Eye Injection Product
Table 79. Novartis Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Eye Injection Product
Table 84. Bayer Recent Developments/Updates
Table 85. Genentech Corporation Information
Table 86. Genentech Description and Business Overview
Table 87. Genentech Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Genentech Eye Injection Product
Table 89. Genentech Recent Developments/Updates
Table 90. Apellis Pharmaceuticals, Inc. Corporation Information
Table 91. Apellis Pharmaceuticals, Inc. Description and Business Overview
Table 92. Apellis Pharmaceuticals, Inc. Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Apellis Pharmaceuticals, Inc. Eye Injection Product
Table 94. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 95. Coherus BioSciences Inc. Corporation Information
Table 96. Coherus BioSciences Inc. Description and Business Overview
Table 97. Coherus BioSciences Inc. Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Coherus BioSciences Inc. Eye Injection Product
Table 99. Coherus BioSciences Inc. Recent Developments/Updates
Table 100. Iveric Bio
Corporation Information
Table 101. Iveric Bio
Description and Business Overview
Table 102. Iveric Bio
Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Iveric Bio
Eye Injection Product
Table 104. Iveric Bio
Recent Developments/Updates
Table 105. Regeneron Corporation Information
Table 106. Regeneron Description and Business Overview
Table 107. Regeneron Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Regeneron Eye Injection Product
Table 109. Regeneron Recent Developments/Updates
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Roche Eye Injection Product
Table 114. Roche Recent Developments/Updates
Table 115. Fagron Corporation Information
Table 116. Fagron Description and Business Overview
Table 117. Fagron Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Fagron Eye Injection Product
Table 119. Fagron Recent Developments/Updates
Table 120. Qilu Pharmaceutical Co.,Ltd. Corporation Information
Table 121. Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
Table 122. Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Qilu Pharmaceutical Co.,Ltd. Eye Injection Product
Table 124. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 125. Chengdu Kanghong Pharmaceutical Group Corporation Information
Table 126. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
Table 127. Chengdu Kanghong Pharmaceutical Group Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Chengdu Kanghong Pharmaceutical Group Eye Injection Product
Table 129. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Eye Injection Distributors List
Table 133. Eye Injection Customers List
Table 134. Eye Injection Market Trends
Table 135. Eye Injection Market Drivers
Table 136. Eye Injection Market Challenges
Table 137. Eye Injection Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Eye Injection
Figure 2. Global Eye Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Eye Injection Market Share by Type in 2023 & 2030
Figure 4. Ranibizumab Product Picture
Figure 5. Bevacizumab Product Picture
Figure 6. Aflibercept Product Picture
Figure 7. Brolucizumab Product Picture
Figure 8. Faricimab Product Picture
Figure 9. Others Product Picture
Figure 10. Global Eye Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Eye Injection Market Share by Application in 2023 & 2030
Figure 12. Age-related Macular Degeneration (AMD)
Figure 13. Diabetic Retinopathy
Figure 14. Retinal Vein Occlusion (RVO)
Figure 15. Retinopathy of Prematurity (ROP)
Figure 16. Uveitis
Figure 17. Neovascular Glaucoma
Figure 18. Others
Figure 19. Global Eye Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Eye Injection Market Size (2019-2030) & (US$ Million)
Figure 21. Global Eye Injection Sales (2019-2030) & (K Units)
Figure 22. Global Eye Injection Average Price (US$/Unit) & (2019-2030)
Figure 23. Eye Injection Report Years Considered
Figure 24. Eye Injection Sales Share by Manufacturers in 2023
Figure 25. Global Eye Injection Revenue Share by Manufacturers in 2023
Figure 26. The Global 5 and 10 Largest Eye Injection Players: Market Share by Revenue in 2023
Figure 27. Eye Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 28. Global Eye Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 29. North America Eye Injection Sales Market Share by Country (2019-2030)
Figure 30. North America Eye Injection Revenue Market Share by Country (2019-2030)
Figure 31. United States Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Canada Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Europe Eye Injection Sales Market Share by Country (2019-2030)
Figure 34. Europe Eye Injection Revenue Market Share by Country (2019-2030)
Figure 35. Germany Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. France Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. U.K. Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Italy Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Netherlands Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Asia Pacific Eye Injection Sales Market Share by Region (2019-2030)
Figure 41. Asia Pacific Eye Injection Revenue Market Share by Region (2019-2030)
Figure 42. China Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Japan Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. South Korea Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. India Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. China Taiwan Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Australia Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Eye Injection Sales Market Share by Country (2019-2030)
Figure 50. Latin America Eye Injection Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Eye Injection Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Eye Injection Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. UAE Eye Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Eye Injection by Type (2019-2030)
Figure 60. Global Revenue Market Share of Eye Injection by Type (2019-2030)
Figure 61. Global Eye Injection Price (US$/Unit) by Type (2019-2030)
Figure 62. Global Sales Market Share of Eye Injection by Application (2019-2030)
Figure 63. Global Revenue Market Share of Eye Injection by Application (2019-2030)
Figure 64. Global Eye Injection Price (US$/Unit) by Application (2019-2030)
Figure 65. Eye Injection Value Chain
Figure 66. Eye Injection Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
